Corneal Implants Market Size By Tissue Type (Human Donor, Artificial Cornea), By Transplant Type (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty, Penetrating Keratoplasty), By Condition (Fungal Keratitis, Fuchs’ Dystrophy, Keratoconus), By End-use (Hospitals, Eye Clinics, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028

Industry Overview

Corneal Implants Market size surpassed USD 325 million in 2021 and is expected to witness 6.4% CAGR from 2022 to 2028. Increasing advancements in corneal implants technology and consistent research and development will augment the market expansion. Availability of cost-efficient implants with biocompatibility, enhanced effectiveness and safety in the artificial cornea transplant is expected to support the market growth. Moreover, increasing awareness about the availability of the artificial cornea and corneal implants as a treatment procedure for the corneal rupture will drive the market demand.
 

Get more details on this report - Request Free Sample PDF
 

COVID-19 pandemic negatively impacted the corneal implants market. As amid pandemic, the non-essential surgeries were at halt to manage COVID-19 patients. For instance, according to EBAI (Eye Bank Association of India), the number of corneal transplants declined during COVID-19 pandemic outbreak. Corneal implants have emerged as a treatment option for corneal ectasis. Corneal implants are small segments of rings that are embedded in the stroma of the cornea or rings of synthetic material that normalize the topography of the corneal surface, improve contact lens tolerance, restore vision, and delay the need for corneal transplantation.
 

Technological advancements in corneal implants will boost the industry statistics over the analysis period

The corneal implants market is expected to increase at a rapid pace in the future years. The healthcare industry is experiencing high-tech demands as a result of technology improvements. The success of corneal implants for visually impaired people has boosted by the introduction of novel materials with improved biocompatibility and advances in associated technology. For instance, in May 2018, researchers at Newcastle University in the United Kingdom developed a technology to produce 3D printed prosthetic corneas that will allow clinicians all around the world to restore eyesight to patients that have been blinded by cataracts or other corneal disorders. Furthermore, corneal implants have gained therapeutic importance because they provide faster vision recovery and better biomechanical stability. Such scenarios will boost the market size.
 

Surging demand for non-optical grade corneas will augment the market outlook over the projected timeline

Get more details on this report - Request Free Sample PDF
 

Based on tissue type, the corneal implants market is bifurcated into human donor, and artificial cornea. The human donor segment accounted for around 99% market share in 2021. Increasing awareness about eye tissue donation and corneal transplantation will favor segment growth. Donor corneal utilization has increased over the years, primarily due to increased use of non-optical grade corneas for therapeutic purposes. Moreover, reimbursement for donor tissue for corneal surgical procedures will surge the demand for human donor tissues. Such scenarios will positively promote market expansion during the analysis period.
 

Growing demand for minimally invasive surgery will drive the endothelial lamellar keratoplasty segment demand over the forecast timeframe

Get more details on this report - Request Free Sample PDF
 

By transplant type, the corneal implants market is divided into endothelial lamellar keratoplasty, penetrating keratoplasty, anterior lamellar keratoplasty, and others. Among them, the endothelial lamellar keratoplasty segment accounted for around USD 122 million in 2021. Endothelial lamellar is a surgical method of endothelial replacement that is performed through a limbal scleral incision that leaves the surface of the recipient cornea untouched. The demand for endothelial lamellar keratoplasty is high as it reduces the risk of endothelial graft rejection. It also preserves host endothelium with minimal surgical trauma and offers efficient visual rehabilitation relative to penetrating keratoplasty. This surgical procedure has fewer intraoperative and postoperative complications including expulsive hemorrhage, anterior synechia. Such scenarios are expected to fuel the market progress.
 

Increasing awareness among people regarding keratoconus diagnosis will accelerate the overall industry progression

Based on condition, the corneal implants industry is categorized into fungal keratitis, Fuchs’ dystrophy, keratoconus, and others. The keratoconus segment accounted for more than 26% market share in 2021. Keratoconus is an eye disease in which the cornea gradually bulges and loses its initial thin, round shape, resulting in a cone-like shape. According to the Eye Bank Association of America, keratoconus affects one in every 2,000 Americans. It generally manifests early in life and is most prevalent among teenagers and adults.
 

Additionally, keratoconus corneas cannot manage ultraviolet light induced oxidative stress and thus, will increase disease prevalence over the coming years. Increasing awareness among people regarding corneal topography for keratoconus diagnosis will further surge the corneal implants business outlook.
 

Availability of effective treatment and better facilities at hospitals will foster the market demand

The corneal implants market, based on end-use is categorized into eye clinics, hospitals, and ambulatory surgical centers. The hospital segment accounted for over USD 144 million revenue size in 2021 owing to increasing number of people opting for corneal implants surgeries. Additionally, due to the availability of emergency facilities, well established healthcare infrastructure and presence of skilled healthcare professionals, patient visits to hospitals have increased significantly. Hospitals offers effective treatment and better facilities as they are equipped with highly advanced technology and serve as a base for most of the surgeries conducted worldwide, thus improving patient outcomes and boosting market size.
 

Growing demand for corneal transplant in North America region will stimulate the market statistics

Get more details on this report - Request Free Sample PDF
 

North America corneal implants industry captured over 60% market share in 2021 and is poised to grow substantially during the forthcoming years. High regional growth in the U.S. and Canada is attributed to availability of well-developed medical facilities and multiple treatment options, as well as the presence of major market players in the region. Moreover, the elderly population in the region are susceptible to chronic diseases such as diabetes, are at high risk of developing severe eye diseases. Corneal diseases may result in vision loss. According to Eye Bank Association of America, in 2019, 51,336 corneal transplants were performed in the U.S. All these factors increased the demand for corneal implants thereby, positively influencing the regional market expansion.
 

Innovative strategies by key market players will upsurge growth opportunities in corneal implants business

Some of the prominent players functioning in the corneal implants industry include AJL Ophthalmic SA, KeraMed, Inc., Florida Lions Eye Bank, Alcon Inc., San Diego Eye Bank, Alabama Eye Bank Inc., CorNeat Vision Ltd., Aurolab, DIPOTEX, MicroKpro, Mediphacos, Presbia PLC, Massachusetts Eye and Ear. These industry participants are involved in various growth strategies with continued innovations and technology improvements to sustain market competition in corneal implants business.
 

Some of the recent industry developments:

• In June 2020, AJL Ophthalmic (Spain) received CE Mark approval for ENDO-K PRO. This product approval enabled company to widen its corneal implants product portfolio as well as strengthen its market position.
   
• In January 2020, Mediphacos announced the launch of Keraring Intrastromal Corneal Ring. Such product launches enabled the company to capture larger market share in corneal implants business.
   

The corneal implants market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Tissue Type

• Human donor
• Artificial cornea

By Transplant Type

• Anterior lamellar keratoplasty
• Endothelial lamellar keratoplasty
• Penetrating keratoplasty
• Others

By Condition

• Fungal Keratitis
• Fuchs’ dystrophy
• Keratoconus
• Others

By End-use

• Hospitals
• Eye Clinics
• Ambulatory Surgical Centers

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific 
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa 
  • South Africa
  • Saudi Arabia
  • UAE